These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12769608)

  • 1. Recent progress in the development of subtype selective nicotinic acetylcholine receptor ligands.
    Astles PC; Baker SR; Boot JR; Broad LM; Dell CP; Keenan M
    Curr Drug Targets CNS Neurol Disord; 2002 Aug; 1(4):337-48. PubMed ID: 12769608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective analgesic acting via neuronal nicotinic acetylcholine receptors: I. In vitro characterization.
    Donnelly-Roberts DL; Puttfarcken PS; Kuntzweiler TA; Briggs CA; Anderson DJ; Campbell JE; Piattoni-Kaplan M; McKenna DG; Wasicak JT; Holladay MW; Williams M; Arneric SP
    J Pharmacol Exp Ther; 1998 May; 285(2):777-86. PubMed ID: 9580626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laminar distribution of nicotinic receptor subtypes in human cerebral cortex as determined by [3H](-)nicotine, [3H]cytisine and [3H]epibatidine in vitro autoradiography.
    Sihver W; Gillberg PG; Nordberg A
    Neuroscience; 1998 Aug; 85(4):1121-33. PubMed ID: 9681951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of nicotinic acetylcholine receptor beta subunits in function of human alpha4-containing nicotinic receptors.
    Wu J; Liu Q; Yu K; Hu J; Kuo YP; Segerberg M; St John PA; Lukas RJ
    J Physiol; 2006 Oct; 576(Pt 1):103-18. PubMed ID: 16825297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
    Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity.
    Parker MJ; Beck A; Luetje CW
    Mol Pharmacol; 1998 Dec; 54(6):1132-9. PubMed ID: 9855644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of dopamine, norepinephrine and serotonin release in the rat prefrontal cortex by neuronal nicotinic acetylcholine receptor agonists.
    Rao TS; Correa LD; Adams P; Santori EM; Sacaan AI
    Brain Res; 2003 Nov; 990(1-2):203-8. PubMed ID: 14568345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors.
    Jensen AA; Mikkelsen I; Frølund B; Bräuner-Osborne H; Falch E; Krogsgaard-Larsen P
    Mol Pharmacol; 2003 Oct; 64(4):865-75. PubMed ID: 14500743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Ca2+ ions in nicotinic facilitation of GABA release in mouse thalamus.
    Léna C; Changeux JP
    J Neurosci; 1997 Jan; 17(2):576-85. PubMed ID: 8987780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (+/-)-Epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors.
    Sullivan JP; Decker MW; Brioni JD; Donnelly-Roberts D; Anderson DJ; Bannon AW; Kang CH; Adams P; Piattoni-Kaplan M; Buckley MJ
    J Pharmacol Exp Ther; 1994 Nov; 271(2):624-31. PubMed ID: 7965777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways.
    Gopalakrishnan M; Molinari EJ; Sullivan JP
    Mol Pharmacol; 1997 Sep; 52(3):524-34. PubMed ID: 9281615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The subunit composition and pharmacology of alpha-Conotoxin MII-binding nicotinic acetylcholine receptors studied by a novel membrane-binding assay.
    Salminen O; Whiteaker P; Grady SR; Collins AC; McIntosh JM; Marks MJ
    Neuropharmacology; 2005 Apr; 48(5):696-705. PubMed ID: 15814104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of evoked calcitonin gene-related peptide release from oral mucosa: a potential basis for the pro-inflammatory effects of nicotine.
    Dussor GO; Leong AS; Gracia NB; Kilo S; Price TJ; Hargreaves KM; Flores CM
    Eur J Neurosci; 2003 Nov; 18(9):2515-26. PubMed ID: 14622152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dorsal root ganglion neurons express multiple nicotinic acetylcholine receptor subtypes.
    Genzen JR; Van Cleve W; McGehee DS
    J Neurophysiol; 2001 Oct; 86(4):1773-82. PubMed ID: 11600638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for spare nicotinic acetylcholine receptors and a beta 4 subunit in bovine adrenal chromaffin cells: studies using bromoacetylcholine, epibatidine, cytisine and mAb35.
    Wenger BW; Bryant DL; Boyd RT; McKay DB
    J Pharmacol Exp Ther; 1997 May; 281(2):905-13. PubMed ID: 9152400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 3-Pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors.
    Abreo MA; Lin NH; Garvey DS; Gunn DE; Hettinger AM; Wasicak JT; Pavlik PA; Martin YC; Donnelly-roberts DL; Anderson DJ; Sullivan JP; Williams M; Arneric SP; Holladay MW
    J Med Chem; 1996 Feb; 39(4):817-25. PubMed ID: 8632405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, binding, and modeling studies of new cytisine derivatives, as ligands for neuronal nicotinic acetylcholine receptor subtypes.
    Tasso B; Canu Boido C; Terranova E; Gotti C; Riganti L; Clementi F; Artali R; Bombieri G; Meneghetti F; Sparatore F
    J Med Chem; 2009 Jul; 52(14):4345-57. PubMed ID: 19548687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UB-165: a novel nicotinic agonist with subtype selectivity implicates the alpha4beta2* subtype in the modulation of dopamine release from rat striatal synaptosomes.
    Sharples CG; Kaiser S; Soliakov L; Marks MJ; Collins AC; Washburn M; Wright E; Spencer JA; Gallagher T; Whiteaker P; Wonnacott S
    J Neurosci; 2000 Apr; 20(8):2783-91. PubMed ID: 10751429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.
    Warpman U; Nordberg A
    Neuroreport; 1995 Nov; 6(17):2419-23. PubMed ID: 8747166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel α3β4 nicotinic acetylcholine receptor-selective ligands. Discovery, structure-activity studies, and pharmacological evaluation.
    Zaveri N; Jiang F; Olsen C; Polgar W; Toll L
    J Med Chem; 2010 Nov; 53(22):8187-91. PubMed ID: 20979364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.